Cargando…
Early Pregnancy Screening for Women at High-Risk of GDM Results in Reduced Neonatal Morbidity and Similar Maternal Outcomes to Routine Screening
The Australasian Diabetes in Pregnancy Society recommends screening high-risk women for gestational diabetes mellitus (GDM) before 24 weeks gestation, under the assumption that an earlier diagnosis and opportunity to achieve normoglycemia will minimize adverse outcomes. However, little evidence exis...
Autores principales: | Clarke, Erin, Cade, Thomas J., Brennecke, Shaun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204101/ https://www.ncbi.nlm.nih.gov/pubmed/32411467 http://dx.doi.org/10.1155/2020/9083264 |
Ejemplares similares
-
Abstract #1323394: Maternal and Neonatal Morbidity and Mortality Among COVID-19 Positive Pregnant Women With and Without GDM
por: Al Jumaah, Mohammed, et al.
Publicado: (2022) -
IDF2022-0337 Maternal and Neonatal Morbidity and Mortality Among COVID-19 positive Pregnant Women with and Without GDM
por: Aljumah, M., et al.
Publicado: (2023) -
GDM-complicated pregnancies: focus on adipokines
por: Mallardo, Marta, et al.
Publicado: (2021) -
Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status
por: Nagalla, Srinivasa R., et al.
Publicado: (2015) -
Maternal Plasma Betaine in Middle Pregnancy Was Associated with Decreased Risk of GDM in Twin Pregnancy: A Cohort Study
por: Gong, Xiaoli, et al.
Publicado: (2021)